BG
AUTL

Bellevue Group’s Autolus Therapeutics AUTL Stock Holding History

Bellevue Group’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-41,500
Closed -$97.5K – 151
2024
Q4 		$97.5K Hold
41,500
– – ﹤0.01% 156
2024
Q3 		$151K Buy
41,500
+9,000
+28% +$35.9K ﹤0.01% 152
2024
Q2 		$113K Hold
32,500
– – ﹤0.01% 156
2024
Q1 		$207K Sell
32,500
-17,500
-35% -$109K ﹤0.01% 154
2023
Q4 		$322K Buy
+50,000
New +$191K ﹤0.01% 147
2020
Q1 		– Sell
-62,200
Closed -$821K – 218
2019
Q4 		$821K Buy
62,200
+27,600
+80% +$361K 0.01% 152
2019
Q3 		$430K Buy
34,600
+600
+2% +$7.93K 0.01% 186
2019
Q2 		$547K Buy
+34,000
New +$760K 0.01% 144

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return